CME Info


The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.

Target Audience

This activity has been designed for practicing oncologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists, and the other health professionals interested in the treatment and diagnosis of lymphoma.

Learning Objectives

  • Evaluate the latest treatment strategies for patients with indolent and aggressive forms of B-cell non-Hodgkin lymphoma, such as follicular lymphoma, diffuse large B-cell lymphoma, and mantle cell lymphoma
  • Assess the safety and efficacy of current and emerging therapeutic approaches for the care of patients with Hodgkin lymphoma
  • Compare and contrast the various patient and disease-related factors that may impact therapeutic decisions for patients with newly diagnosed and previously treated CLL
  • Discuss approaches to the care of patients with rare lymphoma subtypes, including Burkitt lymphoma and peripheral T-cell lymphoma
  • Develop strategies to communicate with and utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma 

Accreditation and Certification

Physician Credit

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine, and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit

University of Chicago Medicine is approved as a provider of nursing continuing professional development by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

This live activity is designated for a maximum of 14 continuing nursing education units.

American Board of Internal Medicine MOC Part II Credit

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn 14 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Participant Credit

Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

Educational Grants/Commercial Support

Additional details to be provided soon!

Disclosure Declarations

As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control content of an educational activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Financial relationships are relevant if financial relationship, in any amount exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.


Additionally, the University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


The staff of the Center for Continuing Medical Education, Bio Ascend and the University of Chicago planning team have disclosed that they have no relevant financial relationships with ACCME defined commercial interests.

Symposium Faculty Disclosure Information Coming Soon!